EC Number |
Protein Variants |
Reference |
---|
3.4.24.35 | E402A |
inactive |
709635 |
3.4.24.35 | E402A |
no enzymic activity, competition with isolated collagen-binding domain and with matrix metalloproteinase MMP-2 binding to native and denatured type I collagen |
667516 |
3.4.24.35 | E402A |
site-directed mutagenesis of the catalytic Glu402 results in an inactive enzyme |
683170 |
3.4.24.35 | E402H/H411E |
site-directed mutagenesis, proteolytic inactive MMP-9 mutant, application of the MMP-9 mutant decreases portal and periportal accumulation of collagen and inhibits fibrogenesis induced by CCl4 in mice |
-, 683450 |
3.4.24.35 | E402Q |
site-directed mutagenesis, proteolytic inactive MMP-9 mutant, application of the MMP-9 mutant decreases portal and periportal accumulation of collagen and inhibits fibrogenesis induced by CCl4 in mice, the MMP-9 mutant suppresses transdifferentiation of hepatic stellate cells to the myofibroblast-like phenotype in vitro and in vivo. Adenoviral application of the mutant leads to increased apoptosis of activated hepatic stellate cells |
-, 683450 |
3.4.24.35 | E412D |
site-directed mutagenesis |
652384 |
3.4.24.35 | H401A |
site-directed mutagenesis, proteolytic inactive MMP-9 mutant, application of the MMP-9 mutant decreases portal and periportal accumulation of collagen and inhibits fibrogenesis induced by CCl4 in mice, the MMP-9 mutant suppresses transdifferentiation of hepatic stellate cells to the myofibroblast-like phenotype in vitro and in vivo. Adenoviral application of the mutant leads to increased apoptosis of activated hepatic stellate cells |
-, 683450 |
3.4.24.35 | more |
construction of proteolytically inactive truncated MMP-9 mutant: MMP-9DELTAHem, lacking the hemopexin domain, MMP-9DELTAOG, lacking the OG domain, and MMP-9DELTAOGHem, lacking both the hemopexin and the OG domain |
683170 |
3.4.24.35 | more |
enzyme-deficient MPP-9-/- mice show impaired neutrophil infiltration during zymosan peritonitis, overview |
-, 683525 |
3.4.24.35 | more |
generation of a mutant version lacking the O-glycosylated linker region and hemopexin domains and containing only the protease domain, residues 1-447 |
718355 |